GPBAR1 and Hyperglycemia: Moreover, TGR5 inhibition in mice did not alter fasting blood glucose levels or PTT outcomes under BA treatment conditions (Fig. 6L–N), though the inhibitor SBI-115 induced systemic hyperglycemia potentially through extrahepatic mechanisms.